We are live on ! Find out more
PC

Palo Capital Portfolio holdings

AUM $236M
1-Year Est. Return 5.33%
This Fund
S&P 500
This Quarter Est. Return
-6.94%
1 Year Est. Return
-5.33%
3 Year Est. Return
+34.55%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
-$12.9M
Cap. Flow
-$2.95M
Cap. Flow %
-2.57%
Top 10 Hldgs %
20.26%
Holding
157
New
28
Increased
60
Reduced
38
Closed
25

Top Buys

Rank Stock Value
1
WLY icon
John Wiley & Sons Class A
WLY
+$1.33M
2
UNP icon
Union Pacific
UNP
+$1.03M
3
ELV icon
Elevance Health
ELV
+$963K
4
SLB icon
SLB Ltd
SLB
+$899K
5
META icon
Meta Platforms (Facebook)
META
+$873K

Top Sells

Rank Stock Value
1
MD icon
Pediatrix Medical
MD
+$2.07M
2
INTU icon
Intuit
INTU
+$1.28M
3
PSX icon
Phillips 66
PSX
+$1.25M
4
DOX icon
Amdocs
DOX
+$1.06M
5
BIIB icon
Biogen
BIIB
+$877K

Sector Composition

Rank Sector Weight
1 Technology 19.24%
2 Healthcare 15.39%
3 Industrials 14.96%
4 Consumer Staples 11.93%
5 Consumer Discretionary 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAKK icon
126
Jakks Pacific
JAKK
$301M
$89K 0.08%
+1,047
New +$98.4K
SVU
127
DELISTED
SUPERVALU Inc.
SVU
$88K 0.08%
+1,748
New +$101K
INO icon
128
Inovio Pharmaceuticals
INO
$55.7M
$86K 0.08%
+1,234
New +$108K
KNDI
129
Kandi Technologies Group
KNDI
$67.5M
$83K 0.07%
+15,881
New +$109K
RMTI icon
130
Rockwell Medical
RMTI
$28.4M
$80K 0.07%
+94
New +$136K
ANTH
131
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$75K 0.07%
+1,549
New +$108K
DRWI
132
DELISTED
DragonWave Inc
DRWI
$8K 0.01%
1,656
-447
-21% -$3.23K
ARWR icon
133
Arrowhead Research
ARWR
$11.9B
– –
-12,000
Closed -$86K
BIIB icon
134
Biogen
BIIB
$30B
– –
-2,202
Closed -$877K
CYTK icon
135
Cytokinetics
CYTK
$10.5B
– –
-11,526
Closed -$77K
DLR icon
136
Digital Realty Trust
DLR
$69.7B
– –
-3,950
Closed -$263K
DOV icon
137
Dover
DOV
$27.6B
– –
-11,835
Closed -$671K
DOX icon
138
Amdocs
DOX
$5.92B
– –
-19,465
Closed -$1.06M
INTU icon
139
Intuit
INTU
$86.5B
– –
-12,740
Closed -$1.28M
MD icon
140
Pediatrix Medical
MD
$2.18B
– –
-27,940
Closed -$2.07M
MET icon
141
MetLife
MET
$61.9B
– –
-14,783
Closed -$738K
MPT
142
Medical Properties Trust
MPT
$2.77B
– –
-23,285
Closed -$305K
OXSQ icon
143
Oxford Square Capital
OXSQ
$163M
– –
-20,920
Closed -$141K
PETS icon
144
PetMed Express
PETS
$41.7M
– –
-30,893
Closed -$534K
PSX icon
145
Phillips 66
PSX
$84.9B
– –
-15,579
Closed -$1.25M
RL icon
146
Ralph Lauren
RL
$22.6B
– –
-4,740
Closed -$627K
VMI icon
147
Valmont Industries
VMI
$9.3B
– –
-4,780
Closed -$568K
TUP
148
DELISTED
Tupperware Brands Corporation
TUP
– –
-3,595
Closed -$232K
MMP
149
DELISTED
Magellan Midstream Partners, L.P.
MMP
– –
-2,780
Closed -$224K
PTX
150
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-1,020
Closed -$60K
3 4 5
6
7

Similar funds

PPC
Precision Path Capital New York $233M AUM
HCG
HNA Capital Group Haikou, China $243M AUM 36.37% 1-Year Est. Return
VAM
Visionary Asset Management Houston, Texas $252M AUM 3.81% 1-Year Est. Return
REFI
Requisite Energy Fund I Dallas, Texas $256M AUM
WAM
Watermark Asset Management San Ramon, California $216M AUM 7.54% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
PCM
Piermont Capital Management St. Louis, Missouri $211M AUM 8.09% 1-Year Est. Return
CHA
Cedar Hill Associates Chicago, Illinois $261M AUM 7.91% 1-Year Est. Return

Palo Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Palo Capital held 157 positions worth $115M, down 10% from $128M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Palo Capital's Q3 2015 filing shows 28 new, 60 increased, 38 reduced and 25 closed positions. Its largest new stake was John Wiley & Sons Class A: 25,529 shares worth $1.28M. The largest sale was Pediatrix Medical, an estimated $2.07M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Palo Capital's largest Q3 2015 buy was John Wiley & Sons Class A: 25,529 shares worth $1.28M.
  • Palo Capital added most to Elevance Health in Q3 2015, an estimated $963K increase.
  • Palo Capital's biggest Q3 2015 reduction was Rockwell Automation, cutting an estimated $591K.
  • Palo Capital fully exited Pediatrix Medical in Q3 2015, selling an estimated $2.07M.
  • Palo Capital's ten largest holdings make up 20% of its $115M portfolio in Q3 2015.
  • Palo Capital opened 28 new positions and closed 25 in Q3 2015.
  • Palo Capital's portfolio value fell 10% quarter-over-quarter to $115M.

Based on Palo Capital's 13F filing for Q3 2015, filed 12 Nov 2015.